Auro Impex & Chemicals (AUROIMPEX)₹35.60+4.86%Electrodes & Refractories
In the Mar 2026 quarter (consolidated), Auro Impex & Chemicals reported sales of ₹115 Cr, down 17.3% from Mar 2025, and net profit of ₹3.01 Cr, up 49.8% year on year. For the year to Mar 2026, sales were ₹250 Cr and net profit ₹4.01 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 110 | 173 | 145 | 124 | 139 | 135 | 115 |
| Expenses | 104 | 167 | 139 | 120 | 135 | 131 | 110 |
| Operating Profit | 6.02 | 6.02 | 6.02 | 4.01 | 4.01 | 4.01 | 5.02 |
| OPM % | 6.0% | 3.6% | 4.0% | 3.6% | 3.0% | 3.0% | 4.2% |
| Other Income | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Interest | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 5.01 | 5.01 | 4.01 | 3.01 | 3.01 | 2.01 | 4.01 |
| Tax % | 27.0% | 28.0% | 31.0% | 29.0% | 21.0% | 26.0% | 28.0% |
| Net Profit | 3.01 | 3.01 | 3.01 | 2.01 | 2.01 | 2.01 | 3.01 |
| EPS (Rs) | 3.60 | 2.85 | 2.30 | 2.01 | 1.78 | 1.34 | 2.07 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 151 | 232 | 318 | 263 | 250 |
| Expenses | 145 | 220 | 306 | 254 | 241 |
| Operating Profit | 5.02 | 12.03 | 12.04 | 9.03 | 9.04 |
| OPM % | 3.6% | 5.0% | 3.8% | 3.3% | 3.6% |
| Other Income | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 |
| Interest | 2.99 | 3.99 | 3.99 | 3.99 | 3.99 |
| Depreciation | 0.99 | 0.00 | 0.00 | 0.00 | 0.99 |
| Profit before tax | 3.01 | 8.02 | 9.01 | 6.01 | 6.01 |
| Tax % | 26.0% | 28.0% | 29.0% | 25.0% | 28.0% |
| Exceptional items | 0.00 | 0.00 | 0.03 | −0.02 | 0.00 |
| Net Profit | 2.01 | 6.01 | 6.01 | 5.01 | 4.01 |
| EPS (Rs) | 29.73 | 6.47 | 5.15 | 3.78 | 3.40 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.77 | 8.99 | 11.99 | 12.00 | 11.99 |
| Reserves | 10.99 | 7.99 | 29.95 | 34.95 | 38.94 |
| Borrowings | 39.97 | 48.99 | 34.97 | 62.95 | 42.95 |
| Other Liabilities | 10.95 | 15.93 | 13.94 | 9.94 | 14.93 |
| Total Liabilities | 61.91 | 81.90 | 90.85 | 120 | 109 |
| Fixed Assets | 8.96 | 8.97 | 9.97 | 11.95 | 16.94 |
| CWIP | 1.01 | 3.01 | 6.01 | 6.01 | 5.01 |
| Investments | 0.00 | 0.00 | 0.00 | 1.01 | 2.01 |
| Other Assets | 52.94 | 69.92 | 74.87 | 101 | 85.85 |
| Inventories | 22.32 | 28.00 | 34.27 | 34.19 | 44.89 |
| Trade receivables | 16.58 | 14.93 | 17.67 | 44.30 | 21.91 |
| Cash & equivalents | 7.48 | 12.81 | 11.07 | 10.92 | 12.83 |
| Total Assets | 61.91 | 81.90 | 90.85 | 120 | 109 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | −4.01 | 3.01 | 1.01 | −22.05 | 23.05 |
| Cash from investing activity | −3.01 | −3.01 | −4.01 | −4.01 | −4.01 |
| Cash from financing activity | 9.03 | 5.02 | 1.01 | 26.08 | −17.07 |
| Net cash flow | 2.99 | 4.99 | −1.99 | 0.00 | 1.99 |
| Capex | 2.65 | 3.06 | 3.85 | 3.87 | 3.89 |
| Free cash flow | −7.01 | 0.00 | −2.99 | −25.98 | 19.98 |
| CFO / OP % | −68.0% | 31.0% | 32.0% | −227.0% | 266.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 39 | 23 | 19 | 61 | 31 |
| Inventory days | 59 | 48 | 42 | 51 | 72 |
| Days payable | 16 | 7 | 8 | 9 | 18 |
| Cash conversion cycle | 85 | 67 | 57 | 106 | 88 |
| Working capital days | 16 | 9 | 31 | 37 | 31 |
| ROCE % | — | 21.0% | 18.0% | 11.0% | 10.0% |
For the Mar 2026 quarter, Auro Impex & Chemicals reported sales of ₹115 Cr, down 17.3% year on year and net profit of ₹3.01 Cr, up 49.8% year on year. The operating margin was 4.2%.
Auro Impex & Chemicals' sales for the year to Mar 2026 were ₹250 Cr.
Net profit for the year to Mar 2026 was ₹4.01 Cr. Earnings per share over the same trailing period were ₹3.40.
Auro Impex & Chemicals reported borrowings of ₹42.95 Cr at Mar 2026, against cash and equivalents of ₹12.83 Cr.
Cash from operations was ₹23.05 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹19.98 Cr.